2021
“Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.” JBMR Plus. Publisher’s Version
2021. “Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption.” eLife. Publisher’s Version
2021. “Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones”. Publisher’s Version
2020
2020. “A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction .” Nature Communications. Publisher’s Version
Zhou Pierce KA Chang Sykes DB Aziz NB Elmariah Ngo Pajevic PD Govea Kestenbaum BR Boer IH WWS de Simic P, Kim W. 2020. “Glycerol-3-phosphate is a FGF23 regulator derived from the injured kidney. .” Journal of Clinical Investigation.
2019
Azab Kochen Santos RNCE Shi Kobayashi Wein MN Divieti Pajevic P. EAC Sun N, Uda Y. 2019. “Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.” J Biol Chem.
Castro CD Noda Cetinbas Silva Martins Ayturk Brooks DJ Bruce Nagata Ono Janto HMJU da Nishimori S, O’Meara MJ. 2019. “Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.” Journal of Clinical Investigation.
2018
Wein MN and Kronenberg HM. 8/1/2018. “Regulation of Bone Remodeling by Parathyroid Hormone.” Cold Spring Harb Perspect Med.
Fisher DE Xavier RJ Kronenberg HM. Wein MN, Foretz M. 2018. “Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. .” Trends Endocrinol Metab.
2017
5/2017. “Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts.”.
2/2017. “Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots.”.
2016
10/19/2016. “SIKs control osteocyte responses to parathyroid hormone.”
6/30/2016. “Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease.”
2015
7/3/2015. “The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.”
3/30/2015. “HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.”.
2012
5/22/2012. “Control of bone resorption in mice by Schnurri-3.”.